The Economics of Telehealth Infrastructure: Is It Still Worth the Heavy Investment?

Updated on June 23, 2026

Telehealth is no longer the emergency workaround it was in 2020.

That phase is over.

Patients are no longer impressed simply because a clinic offers video calls. Employers are no longer excited by a digital waiting room. Investors no longer accept “we are building a telehealth platform” as a strategy by itself.

The question has changed.

It is no longer: can healthcare be delivered online?

It can.

The harder question is: can telehealth infrastructure still justify the cost?

For serious operators, the answer is yes — but only if the infrastructure is doing more than hosting appointments.

The cheap version of telehealth is not enough

At its simplest, telehealth looks inexpensive.

A booking form. A video link. A payment gateway. A doctor on the other end.

That version may work for a small number of low-complexity consultations, but it does not scale well. It also does not create much defensibility.

Modern telehealth infrastructure is expensive because real healthcare is messy.

It needs identity checks, privacy controls, clinical documentation, secure messaging, ePrescribing, pathology workflows, referral management, payment systems, patient support, data storage, audit trails, practitioner onboarding, compliance processes and escalation pathways.

That is before marketing, doctor recruitment, indemnity, security, quality assurance and customer service.

The heavy investment is not in the video call.

It is in everything around the video call that makes the service safe, compliant and repeatable.

The hidden costs are operational

Telehealth businesses often underestimate the operational layer.

Patients do not simply book and disappear.

They ask questions.

They upload the wrong file.

They miss the doctor’s call.

They want a prescription resent.

They need a certificate corrected.

They ask whether their pathology referral is valid.

They request refunds.

They need follow-up.

They forget passwords.

They use the service at odd hours, from different devices, with different levels of digital literacy.

Every one of those moments needs a system.

If the platform does not handle them efficiently, the cost lands on staff. And staff costs can quietly destroy the margin of what looked like a scalable digital service.

The economics of telehealth depend heavily on how much human admin is required per consult.

Good infrastructure reduces that burden.

Poor infrastructure just moves the waiting room online.

Compliance is not a side expense

In healthcare, compliance is part of the product.

A platform that cuts corners may look cheaper at the beginning, but the risk compounds. Telehealth prescribing, privacy, patient assessment, clinical documentation and practitioner governance all need careful handling.

Regulators have made it clear that online healthcare cannot become tick-box medicine. A safe telehealth model needs real clinical assessment, appropriate prescribing standards and clear escalation when online care is not suitable.

This is where infrastructure matters.

The platform should make good clinical behaviour easier, not harder.

It should support proper history-taking, safe prescribing, documentation, secure communication, doctor review, and patient follow-up.

If a telehealth business has to rely on individual clinicians manually compensating for poor systems, the infrastructure is not mature enough.

Where the return on investment actually comes from

The ROI of telehealth infrastructure rarely comes from one dramatic saving.

It comes from many small efficiencies repeated thousands of times.

Fewer abandoned bookings.

Cleaner intake forms.

Faster eligibility checks.

Reduced admin handling.

Better prescription workflows.

Automated but safe patient communication.

Fewer support tickets.

Lower no-show rates.

Shorter turnaround times.

Better doctor utilisation.

Improved patient retention.

A smoother patient experience.

Telehealth ROI is often a workflow story, not a technology story.

The platform has to reduce friction for both sides: patient and clinician.

If it only looks good to the patient but creates chaos for doctors, it fails.

If it is clinically neat but confusing for patients, it also fails.

The economics work when both experiences improve at the same time.

Why patients still want it

Even after the pandemic spike settled, patient expectations did not fully return to the old model.

People are busy.

GP appointments can be hard to access.

Out-of-pocket costs are rising in many markets.

Regional patients still face distance barriers.

Parents do not want to take a sick child into a waiting room unnecessarily.

Workers do not want to lose half a day for a simple request.

Patients now understand that some healthcare needs can be handled online.

Not all.

But some.

That distinction matters.

Telehealth is strongest when it does not pretend to replace every form of care. It is strongest when it handles suitable clinical scenarios well and redirects patients appropriately when in-person assessment is needed.

The Australian example

Australia is an interesting case because the country combines urban access pressure with enormous geography.

A patient in central Melbourne and a patient in regional Western Australia may have very different access problems, but both may benefit from well-designed digital healthcare when the clinical need is suitable.

This is where an Australian telehealth platform such as Doctor Help can position itself clearly: not as a replacement for hospitals or long-term in-person GP relationships, but as a practical digital access point for everyday healthcare needs such as telehealth consultations, medical certificates, prescriptions, referrals and pathology pathways where clinically appropriate.

That positioning matters commercially.

The winning platforms will not be the ones claiming telehealth can do everything.

They will be the ones that know exactly what telehealth should do — and build reliable infrastructure around those use cases.

The investment case in 2026

Telehealth infrastructure is still worth the investment if it creates one or more of the following advantages:

lower marginal cost per consult

better clinical governance

faster patient throughput without lowering quality

stronger practitioner productivity

lower support workload

better retention

safer prescribing and documentation

cleaner integrations with pharmacies, pathology and referral systems

more reliable compliance reporting

better data for operational decisions

But the investment is harder to justify if the platform is just a branded booking form layered over manual work.

Healthcare operators should be honest about this.

Technology does not automatically create scale.

Technology creates scale when it removes repeated friction without creating new clinical risk.

Build for trust, not just transactions

The next stage of telehealth will be judged less by convenience and more by trust.

Patients will ask: is this safe?

Doctors will ask: is this clinically workable?

Regulators will ask: is the assessment adequate?

Investors will ask: is the margin real?

Operators will ask: can we support growth without admin costs exploding?

The platforms that survive will be those that treat infrastructure as clinical infrastructure, not just software.

That means secure systems, careful workflows, proper doctor assessment, patient education, escalation pathways and operational discipline.

It is not cheap.

But neither is building a healthcare brand that patients and clinicians do not trust.

So, is it still worth it?

Yes — if the business understands what it is really buying.

Telehealth infrastructure is not worth heavy investment because video calls are exciting.

It is worth investing in because access, workflow, clinical safety and patient expectations have changed permanently.

The return is not in digitising the appointment.

The return is in building a system where suitable healthcare can move faster, safer and with less friction than the old model allowed.

That is still a valuable business case.But only for platforms willing to build beyond the surface.

14556571 1295515490473217 259386398988773604 o
+ posts

The Editorial Team at Healthcare Business Today is made up of experienced healthcare writers and editors, led by managing editor Daniel Casciato, who has over 25 years of experience in healthcare journalism. Since 1998, our team has delivered trusted, high-quality health and wellness content across numerous platforms.

Disclaimer: The content on this site is for general informational purposes only and is not intended as medical, legal, or financial advice. No content published here should be construed as a substitute for professional advice, diagnosis, or treatment. Always consult with a qualified healthcare or legal professional regarding your specific needs.

See our full disclaimer for more details.